Tag: GxP compliance

Using Mystery Audits and Gemba Walks to Test Real-Life DI Practices Implementing Mystery Audits and Gemba Walks to Assess and Enhance Data Integrity Practices In the pharmaceutical industry, maintaining data integrity is a regulatory expectation and a critical element of Good Manufacturing Practice (GMP) compliance. Regulators such as the FDA, EMA, and MHRA emphasize that…

Read More “Using Mystery Audits and Gemba Walks to Test Real-Life DI Practices” »

Integrating Data Integrity Requirements Into URS and System Design Step-by-Step Guide to Integrating Data Integrity Requirements Into URS and System Design Pharmaceutical manufacturers operating within the US, UK, and EU environments face stringent requirements to assure data integrity throughout GxP computerized systems. As regulators increase focus on compliance with ALCOA+ principles, 21 CFR Part 11…

Read More “Integrating Data Integrity Requirements Into URS and System Design” »

Reviewing Vendor-Hosted Solutions for Data Integrity Controls and GxP Readiness Comprehensive Step-by-Step Guide to Reviewing Vendor-Hosted Solutions for Data Integrity and GxP Readiness In pharmaceutical manufacturing and clinical operations, adherence to data integrity requirements and GxP readiness remains an essential pillar assuring product quality and patient safety. The increasing adoption of vendor-hosted solutions, including cloud-based…

Read More “Reviewing Vendor-Hosted Solutions for Data Integrity Controls and GxP Readiness” »

Data Integrity Considerations in AI-Enabled and Advanced Analytics Platforms Ensuring Robust Data Integrity in AI-Enabled and Advanced Analytics Platforms for Pharma Pharmaceutical manufacturers operating under strict regulatory frameworks in the US, UK, and EU must ensure data integrity throughout their quality and manufacturing systems. The advent of AI-enabled and advanced analytics platforms introduces new challenges…

Read More “Data Integrity Considerations in AI-Enabled and Advanced Analytics Platforms” »

Building a Data Integrity Heatmap to Prioritize Remediation Activities How to Build a Data Integrity Heatmap to Prioritize Remediation Activities Ensuring data integrity throughout manufacturing and clinical operations is a foundational requirement for pharmaceutical quality systems worldwide. Adherence to principles such as ALCOA+ and compliance with key regulations including 21 CFR Part 11 (US FDA)…

Read More “Building a Data Integrity Heatmap to Prioritize Remediation Activities” »

Root Cause Analysis Techniques Tailored for Data Integrity Incidents Root Cause Analysis Techniques Tailored for Data Integrity Incidents Ensuring robust data integrity is a critical compliance pillar within pharmaceutical Good Manufacturing Practice (GMP). Regulatory frameworks such as 21 CFR Part 11 (US FDA), Annex 11 (EU GMP Volume 4), and PIC/S guidelines emphasize maintaining trustworthy…

Read More “Root Cause Analysis Techniques Tailored for Data Integrity Incidents” »

Handling Misleading, Incomplete or Ambiguous Entries in GMP Records Step-by-Step Guide to Handling Misleading, Incomplete or Ambiguous Entries in GMP Records Good Manufacturing Practice (GMP) records are the cornerstone of pharmaceutical quality systems, ensuring product safety, efficacy, and compliance with regulatory requirements. Accurate and truthful documentation is essential to maintain data integrity across the product…

Read More “Handling Misleading, Incomplete or Ambiguous Entries in GMP Records” »

Designing Data Integrity KPIs and Dashboards for Site and Corporate Management Implementing Effective Data Integrity KPIs and Dashboards: A Step-by-Step Guide for Pharma Management In pharmaceutical manufacturing and clinical operations, maintaining robust data integrity is essential not only for compliance with regulatory frameworks such as 21 CFR Part 11 and Annex 11, but also for…

Read More “Designing Data Integrity KPIs and Dashboards for Site and Corporate Management” »

Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes In the pharmaceutical industry, the integrity of data underpins every regulatory decision, product release, and patient safety measure. Data integrity challenges can compromise GxP records and erode confidence in compliance systems, ultimately risking public health…

Read More “Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes” »

Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes Building a Robust Quality Culture to Ensure Data Integrity in Pharma Manufacturing In pharmaceutical manufacturing and clinical operations, data integrity forms the backbone of compliance with Good Manufacturing Practice (GMP) and regulatory expectations. Ensuring reliable, accurate, and complete data in GxP records is imperative for…

Read More “Quality Culture and Data Integrity: How Behaviours Drive Compliance Outcomes” »